CFTR and cystic fibrosis: Indeed, the ‘highly effective’ triple combination of CFTR modulators, which is composed of these two correctors plus the potentiator VX-770, has demonstrated substantial clinical benefit for individuals with CF carrying the F508del mutation in at least one allele [19,20].